UFP Technologies (NASDAQ:UFPT) reported second-quarter 2026 sales growth of 15.1% to $174 million, supported by broad-based demand across its medical technology portfolio, while adjusted earnings per share rose 16.8% to a company-record $2.92.
President and Chief Executive Officer Mitch Rock, speak
What Happened? Shares of medical products company UFP Technologies (NASDAQ:UFPT) jumped 18.5% in the morning session after the company reported impressive se...
UFP Technologies (NASDAQ:UFPT) held its second-quarter earnings conference call on Tuesday. Below is the complete transcript from the call. This transcript is brought to you by Benzinga APIs. For real-time access to our
Medical products company UFP Technologies (NASDAQ:UFPT) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 15.1% year on y...
Medical products company UFP Technologies (NASDAQ:UFPT) will be reporting results this Monday after market hours. Here’s what you need to know. UFP Technolog...
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f...
As small caps outpace the S&P 500 in 2026's rotation, UFP Technologies, Willdan Group, and NWPX Infrastructure show earnings and growth catalysts worth watching this year.
Over the past six months, UFP Technologies’s shares (currently trading at $244.72) have posted a disappointing 8.2% loss, well below the S&P 500’s 7.7% gain....
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have be...
Each stock in this article is trading near its 52-week high. These elevated prices usually indicate some degree of investor confidence, business improvements...
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Not...
Wrapping up Q1 earnings, we look at the numbers and key takeaways for the drug development inputs & services stocks, including UFP Technologies (NASDAQ:UFPT)...
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However,...
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic...
UFP Technologies delivered results in line with Wall Street’s revenue expectations for Q1 and outperformed on adjusted profitability, driving a positive mark...
Medical products company UFP Technologies (NASDAQ:UFPT) met Wall Street’s revenue expectations in Q1 CY2026, with sales up 4.1% year on year to $154.2 millio...
Medical products company UFP Technologies (NASDAQ:UFPT) met Wall Street’s revenue expectations in Q1 CY2026, with sales up 4.1% year on year to $154.2 millio...
Medical products company UFP Technologies (NASDAQ:UFPT) will be reporting earnings this Monday after market close. Here’s what you need to know. UFP Technolo...
What Happened? A number of stocks jumped in the afternoon session after the reopening of the Strait of Hormuz signaled a cooling of global logistics and ener...
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...
